ALCAINE Side Effects

6538028-8 | Asthenia, Blood Pressure Decreased, Haemodynamic Instability, Hyperhidrosis, Loss Of Consciousness, Tremor
on Dec 29, 2009 Male patient from UKRAINE , 38 years of age, was diagnosed with foreign body in eye and was treated with Alcaine (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood pressure decreased, haemodynamic instability, hyperhidrosis, loss of consciousness, tremor. Alcaine dosage: 1 Gtt Once Ophthalmic.

6472824-0 | Asthenia, Blood Pressure Decreased, Hyperhidrosis, Loss Of Consciousness, Tremor
Patient was taking Alcaine (View Usage). Patient had the following side effects: asthenia, blood pressure decreased, hyperhidrosis, loss of consciousness, tremor on Nov 23, 2009 from UKRAINE Additional patient health information: Male patient , 38 years of age, was diagnosed with foreign body in eye and. Alcaine dosage: 1 Gtt Once Ophthalmic.

5155550-X | Application Site Reaction, Hypersensitivity, Visual Disturbance
Adverse event was reported on Oct 27, 2006 by a Female patient taking Alcaine (View Usage) (Dosage: ) . Location: UNITED STATES , 48 years of age, After Alcaine was administered, patient had the following side effects: application site reaction, hypersensitivity, visual disturbance.

5100523-6 | Application Site Pain, Heart Rate Decreased, Postictal State, Tonic Clonic Movements, Unresponsive To Stimuli
on Sep 07, 2006 Male patient from UNITED STATES , 41 years of age, weighting 230.0 lb, was diagnosed with eye injury and was treated with Alcaine (View Usage). Patient experienced the following unwanted or unexpected effects: application site pain, heart rate decreased, postictal state, tonic clonic movements, unresponsive to stimuli. Alcaine dosage: 2 Drops Once Ophthalmic. During the same period patient was treated with FLUORETS CHAUVIN (1 Unit Once Ophthalmic) (View Fluorets Chauvin Review and Fluorets Chauvin Label ).


5083743-9 | Emphysema, Myocardial Infarction, Pain, Purulence, Pyelonephritis
on Jul 28, 2006 Female patient from BRAZIL , 40 years of age, was diagnosed with intraocular pressure test, fundoscopy and was treated with Alcaine (View Usage). Patient had the following side effects: emphysema, myocardial infarction, pain (What is pain?), purulence, pyelonephritis. Alcaine dosage: Opht. During the same period patient was treated with MYDRIACYL (Opht) (View Mydriacyl Review and Mydriacyl Label ), FLUORESCEIN SODIUM (View Fluorescein Sodium Review and Fluorescein Sodium Label ).

5067641-2 | Cardiac Arrest, Malaise, Myocardial Infarction
Patient was taking Alcaine (View Usage). After Alcaine was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), malaise, myocardial infarction on Jul 13, 2006 from BRAZIL Additional patient health information: Female patient , 41 years of age, was diagnosed with intraocular pressure test, fundoscopy and. Alcaine dosage: Opht {1 Month. During the same period patient was treated with MYDRIACYL (Opht) (View Mydriacyl Review and Mydriacyl Label ).

4996137-9 | Conjunctival Hyperaemia, Corneal Epithelium Defect, Corneal Infiltrates, Corneal Neovascularisation, Factitious Disorder, Keratopathy, Major Depression
Adverse event was reported on Apr 21, 2006 by a Female patient taking Alcaine (View Usage) (Dosage: ) . Location: UNITED STATES , 21 years of age, Patient experienced the following unwanted or unexpected effects: conjunctival hyperaemia, corneal epithelium defect, corneal infiltrates, corneal neovascularisation, factitious disorder, keratopathy, major depression. Patient was hospitalized and became disabled.

4996136-7 | Blepharitis, Conjunctival Hyperaemia, Corneal Epithelium Defect, Corneal Infiltrates, Dermatitis Contact, Eye Pain, Factitious Disorder, Hypopyon
on Apr 21, 2006 Female patient from UNITED STATES , 19 years of age, was treated with Alcaine (View Usage). Patient had the following side effects: blepharitis, conjunctival hyperaemia, corneal epithelium defect, corneal infiltrates, dermatitis contact, eye pain, factitious disorder, hypopyon. Alcaine dosage: . Patient was hospitalized and became disabled.